| Dr Teresa C Cisneros, MD EDD | |
|
2707 Browns Lane, Jonesboro, AR 72401 | |
| (870) 972-4939 | |
| (870) 972-4911 |
| Full Name | Dr Teresa C Cisneros |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 31 Years |
| Location | 2707 Browns Lane, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154396000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | C8462 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uhs Of Provo Canyon Inc | 8729250543 | 3 |
News Archive
In 2007, RaySearch Laboratories AB and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
Newspapers focus on a few of the major players in health care reform: Sens. Olympia Snowe, R-Maine; George Voinovich, R-Ohio; Sherrod Brown, D-Ohio; and Judd Gregg, R-N.H.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
› Verified 6 days ago
| Entity Name | Uhs Of Provo Canyon Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457617409 PECOS PAC ID: 8729250543 Enrollment ID: O20121015000587 |
News Archive
In 2007, RaySearch Laboratories AB and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
Newspapers focus on a few of the major players in health care reform: Sens. Olympia Snowe, R-Maine; George Voinovich, R-Ohio; Sherrod Brown, D-Ohio; and Judd Gregg, R-N.H.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
› Verified 6 days ago
| Entity Name | Pyramis Medical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750091781 PECOS PAC ID: 8224400908 Enrollment ID: O20230206001771 |
News Archive
In 2007, RaySearch Laboratories AB and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
Newspapers focus on a few of the major players in health care reform: Sens. Olympia Snowe, R-Maine; George Voinovich, R-Ohio; Sherrod Brown, D-Ohio; and Judd Gregg, R-N.H.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa C Cisneros, MD EDD 2707 Browns Lane, Jonesboro, AR 72401 Ph: (870) 972-4939 | Dr Teresa C Cisneros, MD EDD 2707 Browns Lane, Jonesboro, AR 72401 Ph: (870) 972-4939 |
News Archive
In 2007, RaySearch Laboratories AB and TomoTherapy Incorporated (now Accuray) entered into a software licensing and development agreement. Under the agreement, RaySearch developed a product named SharePlan, which was launched by TomoTherapy in 2009.
The U.S. Food and Drug Administration (FDA) has approved Alinia (nitazoxanide) tablets and oral suspension for treating diarrhea caused by Cryptosporidium parvum infection in adults and children 12 years and older. The product, already approved to treat the same infection in younger children, received a priority review by FDA.
Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.
Newspapers focus on a few of the major players in health care reform: Sens. Olympia Snowe, R-Maine; George Voinovich, R-Ohio; Sherrod Brown, D-Ohio; and Judd Gregg, R-N.H.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Colesevelam HCI 625 mg tablets.
› Verified 6 days ago
Kelly Hair, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4000 Fax: 870-972-4968 | |
Dr. Mary Michelle Wegner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4961 Fax: 870-972-4088 | |
Dr. Mario Cauli, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1107 E Matthews Ave, Suite 200, Jonesboro, AR 72401 Phone: 870-931-4442 Fax: 870-931-4707 | |
Dr. Asra S Khan, PSYD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2707 Browns Lane, Jonesboro, AR 72401 Phone: 870-972-4939 Fax: 870-972-4911 | |
Dr. Sarita Subba, M.D.,MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2707 Browns Ln, Jonesboro, AR 72401 Phone: 870-972-4000 | |
Victor Stewart Mcnerney, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 615 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-930-9090 Fax: 870-931-4581 |